Literature DB >> 12583404

Should high hTg levels in the absence of iodine uptake be treated?

M Biermann1, O Schober.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12583404     DOI： 10.1007/s00259-002-1004-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Should high hTg levels in the absence of iodine uptake be treated?

Authors:  K E Britton; R R Foley; S L Chew
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-04       Impact factor: 9.236

2.  Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment.

Authors:  Leonardo Pace; Michele Klain; Carmine Albanese; Barbara Salvatore; Giovanni Storto; Andrea Soricelli; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-05       Impact factor: 9.236

3.  Influence of TSH on uptake of [18F]fluorodeoxyglucose in human thyroid cells in vitro.

Authors:  J T Deichen; C Schmidt; O Prante; S Maschauer; T Papadopoulos; T Kuwert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

4.  Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity.

Authors:  Martin Biermann; Jostein Kråkenes; Katrin Brauckhoff; Hans Kristian Haugland; Achim Heinecke; Lars A Akslen; Jan Erik Varhaug; Michael Brauckhoff
Journal:  Acta Radiol       Date:  2015-03-13       Impact factor: 1.990
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.